BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

TIGER BIOSCIENCES — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

TIGER BIOSCIENCES

via BALLARD PARTNERS

3rd Quarter (July 1 - Sep 30) · 2025Posted Oct 19, 2025Filing document ↗LDA record ↗

Income$80Kfee reported

Client

Name: TIGER BIOSCIENCES
Description: Biotechnology Company
Location: Pennsylvania · United States of America

Registrant

Firm: BALLARD PARTNERS
Description: Government relations and advocacy services
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Medicare/Medicaid
Guidance and advocacy related to Medicare coverage.
LobbyistsBRIAN BALLARD · DANIEL MCFAUL · GERALD JOHN O'HANLON · MICHAEL LAROSA
Covered position (DANIEL MCFAUL): Legislative Director to U.S. Representative Joe Scarborough; Chief of Staff to U.S. Representatives Jeff Miller and Matt Gaetz
Covered position (MICHAEL LAROSA): (Lobbying limited to Congress) EA, Congresswoman Bean; Assistant to DepDir, OPM; Comm Dir, ENRC, Senate; DPCC, Comm Dir, Speaker Pelosi; Biden Harris Transition Team, Press Sec. First Lady; SA to President Biden; Press Sec. First Lady
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.